We found that MLKL expression was significantly reduced in AML BM (across all genetic or cytogenetic aberrations) (Fig. 1A), which was in line with the MLKL expression in WHO-categorized AML as previously reported [6]. This evidence concerns the gene MLKL and acute myeloid leukemia.